UAE says 97% COVID-19 patients recover after Sotrovimab use

UAE says 97% COVID-19 patients recover after Sotrovimab use
UAE says 97% COVID-19 patients recover after Sotrovimab use

We show you our most important and recent visitors news details UAE says 97% COVID-19 patients recover after Sotrovimab use in the following article

Hind Al Soulia - Riyadh - ABU DHABI — Around 97 percent of coronavirus patients, who took anti-viral medicine Sotrovimab fully recovered within 14 days, said the health ministry of the United Arab Emirates on Saturday, adding that the medication also resulted in 100 percent prevention of death among recipients and 99 percent prevention of admission to ICU.

The latest data on the use of Sotrovimab, a monoclonal antibody treatment delivered through intravenous therapy, comes out after the UAE health ministry in collaboration with the Abu Dhabi Department of Health announced the treatment result of Sotrovimab in treating mild to moderate COVID-19 cases among high-risk patients including adults, pregnant women and children aged 12 and above who are at risk of progressing to severe symptoms and meet other relevant criteria.

According to the ministry, Sotrovimab was administered to 6,175 patients with COVID-19 in Abu Dhabi between June 30 and July 13. About 52 percent of the patients were aged 50 or above, and almost all recipients had multiple comorbidities including obesity, cancer, cardiovascular disease and diabetes.

The UAE health ministry has approved the use of Sotrovimab, which is produced by global biopharmaceutical company GlaxoSmithKline (GSK), after conducting the local evaluation. It has also been approved for emergency use by the US Food and Drug Administration.

The UAE was one of the first countries in the world to receive a shipment of Sotrovimab in mid-June, following an agreement between the Abu Dhabi Health Department, Rafed, a leading group purchasing organization, GSK and Etihad Cargo. — SG


These were the details of the news UAE says 97% COVID-19 patients recover after Sotrovimab use for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at Saudi Gazette and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

PREV FilGoal | News | Labib: Zamalek lived for a...
NEXT Global Electric Heat Tracking Market Research Analysis Report: Growing Demand and...